Gefitinib 250mg Tablets – Advanced Targeted Therapy for EGFR-Positive Lung Cancer
Gefitinib 250mg Tablets are a prescription targeted therapy used in the treatment of EGFR mutation-positive Non-Small Cell Lung Cancer (NSCLC). As an EGFR tyrosine kinase inhibitor (TKI), Gefitinib works by blocking signals that promote cancer cell growth and division, making it an important treatment option for eligible patients under oncologist supervision. The recommended adult dose is typically 250 mg orally once daily, although treatment should always follow a physician's guidance.
Cordium Pharmaceuticals Pvt Ltd is an Indian pharmaceutical exporter supplying oncology medicines to licensed importers, hospitals, pharmacies, healthcare distributors, and other authorized buyers in international markets, including the United States (USA), United Kingdom (UK), United Arab Emirates (UAE), and South Africa. The company supports international pharmaceutical exports with documentation, secure packaging, and logistics assistance.
What is Gefitinib 250mg Used For?
Gefitinib Tablets are indicated for adults with locally advanced or metastatic NSCLC whose tumors have specific activating EGFR mutations confirmed through appropriate testing. It is a prescription medicine and should be initiated only by qualified oncology specialists.
Key Features
Gefitinib 250mg oral tablets
EGFR Tyrosine Kinase Inhibitor (TKI)
Targeted therapy for eligible NSCLC patients
Once-daily oral administration
Prescription-only medicine
Used under oncologist supervision
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd offers:
Reliable international pharmaceutical export services
Secure export-grade packaging
Wholesale and bulk supply support
Documentation assistance for international shipments
Supply for hospitals, oncology clinics, pharmacies, and licensed distributors
Responsive customer support for global inquiries
The company serves buyers across the USA, UK, UAE, South Africa, and additional international markets, subject to local import regulations.
International Export Markets
Cordium Pharmaceuticals Pvt Ltd supports pharmaceutical export requirements for:
USA
United Kingdom (UK)
United Arab Emirates (UAE)
South Africa
Europe
Middle East
Africa
Other eligible international markets
Benefits of Global Pharmaceutical Export Services
Consistent product availability
International shipping support
Bulk procurement options
Export documentation assistance
Secure packaging for international transit
Important Safety Information
Gefitinib is a prescription-only medicine. Treatment should begin only after confirming the appropriate EGFR mutation status and under the supervision of an experienced healthcare professional. Patients should not self-medicate or change their dosage without medical advice. Like all medicines, Gefitinib may cause side effects, and healthcare providers may recommend monitoring during treatment.
Contact Cordium Pharmaceuticals Pvt Ltd
Healthcare institutions, licensed distributors, pharmacies, and authorized buyers seeking information regarding Gefitinib 250mg Tablets can contact Cordium Pharmaceuticals Pvt Ltd for export-related inquiries, product availability, documentation assistance, and international shipping support.
Gefitinib 250mg Tablets are a prescription targeted therapy used in the treatment of EGFR mutation-positive Non-Small Cell Lung Cancer (NSCLC). As an EGFR tyrosine kinase inhibitor (TKI), Gefitinib works by blocking signals that promote cancer cell growth and division, making it an important treatment option for eligible patients under oncologist supervision. The recommended adult dose is typically 250 mg orally once daily, although treatment should always follow a physician's guidance.
Cordium Pharmaceuticals Pvt Ltd is an Indian pharmaceutical exporter supplying oncology medicines to licensed importers, hospitals, pharmacies, healthcare distributors, and other authorized buyers in international markets, including the United States (USA), United Kingdom (UK), United Arab Emirates (UAE), and South Africa. The company supports international pharmaceutical exports with documentation, secure packaging, and logistics assistance.
What is Gefitinib 250mg Used For?
Gefitinib Tablets are indicated for adults with locally advanced or metastatic NSCLC whose tumors have specific activating EGFR mutations confirmed through appropriate testing. It is a prescription medicine and should be initiated only by qualified oncology specialists.
Key Features
Gefitinib 250mg oral tablets
EGFR Tyrosine Kinase Inhibitor (TKI)
Targeted therapy for eligible NSCLC patients
Once-daily oral administration
Prescription-only medicine
Used under oncologist supervision
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd offers:
Reliable international pharmaceutical export services
Secure export-grade packaging
Wholesale and bulk supply support
Documentation assistance for international shipments
Supply for hospitals, oncology clinics, pharmacies, and licensed distributors
Responsive customer support for global inquiries
The company serves buyers across the USA, UK, UAE, South Africa, and additional international markets, subject to local import regulations.
International Export Markets
Cordium Pharmaceuticals Pvt Ltd supports pharmaceutical export requirements for:
USA
United Kingdom (UK)
United Arab Emirates (UAE)
South Africa
Europe
Middle East
Africa
Other eligible international markets
Benefits of Global Pharmaceutical Export Services
Consistent product availability
International shipping support
Bulk procurement options
Export documentation assistance
Secure packaging for international transit
Important Safety Information
Gefitinib is a prescription-only medicine. Treatment should begin only after confirming the appropriate EGFR mutation status and under the supervision of an experienced healthcare professional. Patients should not self-medicate or change their dosage without medical advice. Like all medicines, Gefitinib may cause side effects, and healthcare providers may recommend monitoring during treatment.
Contact Cordium Pharmaceuticals Pvt Ltd
Healthcare institutions, licensed distributors, pharmacies, and authorized buyers seeking information regarding Gefitinib 250mg Tablets can contact Cordium Pharmaceuticals Pvt Ltd for export-related inquiries, product availability, documentation assistance, and international shipping support.
Keywords
